1. Home
  2. RILYP vs REVBW Comparison

RILYP vs REVBW Comparison

Compare RILYP & REVBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RILYP
  • REVBW
  • Stock Information
  • Founded
  • RILYP N/A
  • REVBW N/A
  • Country
  • RILYP United States
  • REVBW United States
  • Employees
  • RILYP 2383
  • REVBW 9
  • Industry
  • RILYP Investment Managers
  • REVBW Biotechnology: Pharmaceutical Preparations
  • Sector
  • RILYP Finance
  • REVBW Health Care
  • Exchange
  • RILYP Nasdaq
  • REVBW Nasdaq
  • Market Cap
  • RILYP N/A
  • REVBW N/A
  • IPO Year
  • RILYP N/A
  • REVBW 2020
  • Fundamental
  • Price
  • RILYP $4.80
  • REVBW $0.02
  • Analyst Decision
  • RILYP
  • REVBW
  • Analyst Count
  • RILYP 0
  • REVBW 0
  • Target Price
  • RILYP N/A
  • REVBW N/A
  • AVG Volume (30 Days)
  • RILYP N/A
  • REVBW N/A
  • Earning Date
  • RILYP N/A
  • REVBW N/A
  • Dividend Yield
  • RILYP N/A
  • REVBW N/A
  • EPS Growth
  • RILYP N/A
  • REVBW N/A
  • EPS
  • RILYP N/A
  • REVBW N/A
  • Revenue
  • RILYP N/A
  • REVBW N/A
  • Revenue This Year
  • RILYP N/A
  • REVBW N/A
  • Revenue Next Year
  • RILYP N/A
  • REVBW N/A
  • P/E Ratio
  • RILYP N/A
  • REVBW N/A
  • Revenue Growth
  • RILYP N/A
  • REVBW N/A
  • 52 Week Low
  • RILYP N/A
  • REVBW N/A
  • 52 Week High
  • RILYP N/A
  • REVBW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RILYP 36.57
  • REVBW N/A
  • Support Level
  • RILYP $4.70
  • REVBW N/A
  • Resistance Level
  • RILYP $5.19
  • REVBW N/A
  • Average True Range (ATR)
  • RILYP 0.46
  • REVBW 0.00
  • MACD
  • RILYP -0.04
  • REVBW 0.00
  • Stochastic Oscillator
  • RILYP 15.56
  • REVBW 0.00

About RILYP B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

About REVBW Revelation Biosciences Inc. Warrant

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: